Angiogenesis
Researchers from Mayo Clinic, Medical Department publish new studies and findings in the area of angiogenesis
Published in Hospital Law Weekly, September 6th, 2007
"We conducted a phase II trial evaluating the clinical efficacy of ABT-510 and its effects on biomarkers of angiogenesis and immunity in patients with metastatic melanoma (MM). A 2-stage phase II clinical trial was conducted to assess the clinical efficacy, safety, and pharmacodynamic effects (angiogenesis and immunity) of ABT-510 in patients with stage IV melanoma. The primary endpoint was 18-week treatment failure rate. Patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2007-09-06)
More Articles from Hospital Law Weekly
- Allergies
Video: Food Allergies Mean Back-to-School Jitters for Millions of Students and Their Parents - Critical Care
Texas Scottish Rite Hospital for Children Selects RedCannon KeyPoint Alchemy for Critical Care of Precious Patient Data - Cysts
Data on cysts published by A. Kurt and colleagues - Depression Risk Factors
Researchers from RAND Corporation publish new studies and findings in the area of depression risk factors - Drug Abuse
Leading Panamanian Hospital Centro Medico Paitilla to Serve as Hythiam's Initial PROMETA Licensee for Central and South America - Epidemiology
Reports summarize epidemiology study results from Vanderbilt University - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
